| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/03/2001 | CA2388942A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | CA2388924A1 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | CA2388921A1 Identical-by-descent fragment enrichment |
| 05/03/2001 | CA2388907A1 Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
| 05/03/2001 | CA2388851A1 Formylglycinamidinribotide synthase from plants |
| 05/03/2001 | CA2388642A1 A method and computer system to design primers utilizing a first and second target nucleotide sequence |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388535A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | CA2388514A1 A novel human metabotropic glutamate receptor |
| 05/03/2001 | CA2388422A1 Heterologous production of polyketides |
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2388332A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | CA2388298A1 The use of csf-1 inhibitors |
| 05/03/2001 | CA2388165A1 Disulfide conjugated cell toxins and methods of making and using them |
| 05/03/2001 | CA2388162A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 05/03/2001 | CA2388149A1 Human homologue of yeast helicase and uses thereof |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387691A1 Novel enzyme |
| 05/03/2001 | CA2387685A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | CA2387680A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | CA2387666A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | CA2387567A1 Double-stranded nucleic acid probes and their use |
| 05/03/2001 | CA2387506A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2387260A1 Non-anaphylactic forms of grass pollen ph1 p 6 allergen and their use |
| 05/03/2001 | CA2386926A1 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | CA2386509A1 G protein-coupled receptors expressed in human brain |
| 05/03/2001 | CA2386090A1 Production of functional hybrid genes and proteins |
| 05/02/2001 | EP1096411A2 Analysis and prediction of protein functional sub-types from protein sequence alignments |
| 05/02/2001 | EP1096255A2 Method for measuring skin absorbability |
| 05/02/2001 | EP1096162A1 Split spool type flexible coupling |
| 05/02/2001 | EP1096024A1 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays |
| 05/02/2001 | EP1096018A1 Complementation cells comprising an inducer and/or a repressor |
| 05/02/2001 | EP1096017A2 Method for increasing the production of physiologically active substances by cultured cells |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096015A2 Method for cloning and expression of the NheI restriction endonuclease in E. coli |
| 05/02/2001 | EP1096014A2 Catalytic domain of the human effector cell cycle checkpoint protein kinase, Chk1, materials and methods for identification of inhibitors thereof |
| 05/02/2001 | EP1096013A2 Nucleotide sequence encoding corynebacterium poxb-gene and its use in the preparation of l-lysine |
| 05/02/2001 | EP1096011A1 Microbiological production method for alpha-l-aspartyl-l-phenylalanine |
| 05/02/2001 | EP1096010A1 Nucleotide sequences coding for branched-chain amino acids export proteins, method for isolating them and their use |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095948A1 Idiotype vaccines |
| 05/02/2001 | EP1095698A2 Method of producing oligonucleotide arrays |
| 05/02/2001 | EP1095279A1 Method for identifying a presenilinase inhibitor |
| 05/02/2001 | EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/02/2001 | EP1095183A2 Methods for the diagnosis and treatment of lung cancer |
| 05/02/2001 | EP1095165A1 Method for identifying mutants and molecules |
| 05/02/2001 | EP1095163A2 Screening of hydrolase libraries for enantioselective enzymes |
| 05/02/2001 | EP1095162A1 Archiving of vectors |
| 05/02/2001 | EP1095159A1 Bone morphogenic protein |
| 05/02/2001 | EP1095158A1 Process and materials for production of glucosamine |
| 05/02/2001 | EP1095156A2 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 05/02/2001 | EP1095155A1 Means and methods for enhancing the content of sulfur compounds in plants |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095153A1 Biological tagatose production by recombinant escherichia coli |
| 05/02/2001 | EP1095152A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 05/02/2001 | EP1095151A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 05/02/2001 | EP1095150A2 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 05/02/2001 | EP1095149A2 Compositions and methods for fumonisin detoxification |
| 05/02/2001 | EP1095148A2 Cloning and characterisation of novel mammalian peptidases |
| 05/02/2001 | EP1095147A2 Polyketides, their preparation, and materials for use therein |
| 05/02/2001 | EP1095146A2 Genes encoding sulfate assimilation proteins |
| 05/02/2001 | EP1095145A1 Pathogen-resistant grape plants |
| 05/02/2001 | EP1095144A2 Enhancer elements for increased translation in plant plastids |
| 05/02/2001 | EP1095143A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 05/02/2001 | EP1095142A2 Molecules associated with cell proliferation |
| 05/02/2001 | EP1095141A2 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5 |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1095139A2 Secreted proteins |
| 05/02/2001 | EP1095138A2 Presenilin 2 specific ribozyme |
| 05/02/2001 | EP1095137A1 Novel promoter sequences of myostatin gene |
| 05/02/2001 | EP1095136A1 Cells and animals deficient in protein kinase c epsilon |
| 05/02/2001 | EP1095135A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 05/02/2001 | EP1095133A1 Ftsz multimeric proteins and their uses |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | EP1095054A1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 05/02/2001 | EP1095051A1 Metal ion-binding mass markers for nucleic acids |
| 05/02/2001 | EP1095050A1 Phosphorous organic compounds and their use |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP1095002A1 Method of vitamin production |
| 05/02/2001 | EP1094863A2 Methods for treating neurological injuries and disorders |
| 05/02/2001 | EP1094836A2 Methods of raising animals for meat production |
| 05/02/2001 | EP1094833A2 Oxidized thymosin beta 4 |
| 05/02/2001 | EP0920496A4 Recombination of polynucleotide sequences using random or defined primers |
| 05/02/2001 | EP0817860B1 Pseudotyped retroviral particles |
| 05/02/2001 | CN1293712A Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 05/02/2001 | CN1293711A Genes encoding MLO proteins and conferring fungal resistance upon plants |
| 05/02/2001 | CN1293710A Mutant recombinant allergens |
| 05/02/2001 | CN1293709A Identification of factors which mediate the interaction of heterotrimeric G proteins and monomeric G proteins |
| 05/02/2001 | CN1293708A Haloperoxidases with altered pH profiles |
| 05/02/2001 | CN1293542A Thermostable phytases in feed preparation and plant expression |
| 05/02/2001 | CN1293253A Polypeptide-human DPB methyltransferase 41 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293252A Zinc finger protein and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293251A Human ankyrin and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293250A Epidermal growth factor like protein and polynucleotide sequence for coding it |
| 05/02/2001 | CN1293249A Human transmembrane glycosyl transport factor and its coding sequence |